Yu Zhou

Randomized clinical trial of pembrolizumab vs chemotherapy for previously untreated Chinese patients with PD‐L1‐positive locally advanced or metastatic non–small‐cell lung cancer: KEYNOTE‐042 China Study

Yi‐Long Wu, Li Zhang, Yun Fan et al. · International Journal of Cancer · 2020 · 99 citations · Full text

Medicine, Oncology, Pharmacology +16

Granulocyte Colony-Stimulating Factor Reduces Cardiomyocyte Apoptosis and Improves Cardiac Function in Adriamycin-Induced Cardiomyopathy in Rats

Xu Hou, J. C. Son, Yang Wang et al. · Cardiovascular Drugs and Therapy · 2006 · 49 citations

Medicine, Cardiology, Pharmacology +12

Interleukin-27 upregulates major histocompatibility complex class II expression in primary human endothelial cells through induction of major histocompatibility complex class II transactivator

Xiao Feng, Xiaoli Chen, Na Liu et al. · Human Immunology · 2007 · 42 citations

Life Sciences, Cell Biology, Immunology +12

Autoantibody profiling identifies predictive biomarkers of response to anti-PD1 therapy in cancer patients

Qiaoyun Tan, Dan Wang, Jianliang Yang et al. · Theranostics · 2020 · 42 citations · Full text

Life Sciences, Immunology, Oncology +17

MFSD2A potentiates gastric cancer response to anti‐PD‐1 immunotherapy by reprogramming the tumor microenvironment to activate T cell response

Bin Zhang, Chun‐Mei Wang, Hao‐Xiang Wu et al. · Cancer Communications · 2023 · 40 citations · Full text

Medicine, Immunology, Oncology +17